All In MedTech

Device Trial Radar · NCT06394739

RevCore for In Stent Thrombosis

RevCore for In Stent Thrombosis (REVIT)

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Sep 9, 2024

Primary completion

Apr 2027

Study completion Apr 2028

Sponsor

Lead sponsor
Inari MedicalNot on our public-company list
Sponsor type
Industry
First posted
May 1, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.

Conditions

  • In-stent Thrombosis

Interventions

  • ThrombectomyDevice

    RevCore Thrombectomy to treat in-stent thrombosis

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evidence of successful stent recanalizationTime frame: Immediately after the RevCore thrombectomy procedure for in-stent thrombosis

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Yale University

    New Haven, Connecticut · Recruiting

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.